Eyewire News: The Podcast
03.18.26
Alcon and Lensar provide a major update to their proposed merger; the latest IOL on Johnson & Johnson’s Tecnis platform receives FDA approval; and the FDA issues another CRL to Aldeyra Therapeutics for its investigational dry eye drug reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
03.18.26
Alcon and Lensar Call Off Merger01.21.26
Rayner Launches New Phaco SystemShow More